Dr. Rajiv Agarwal is a practicing nephrologist and a tenured Professor of Medicine at Indiana University School of Medicine at Indianapolis, IN. Dr. Agarwal earned his medical degree from the All India Institute of Medical Sciences in New Delhi. After completing residency in Internal Medicine at the same institution he completed a Nephrology fellowship at University of Texas, Southwestern Dallas. In July 1997, he joined Indiana University as Clinical Assistant Professor and within 10 years was promoted to the rank of full Professor. Dr. Agarwal has published > 250 original papers and reviews in Nephrology. Dr. Agarwal has received the Indiana University Trustee’s teaching award, the young scholar award of the American Society of Hypertension, and the Clinical Excellence award from the American Nephrologists of Indian Origin (ANIO). He serves on the Editorial Board of several nephrology journals and as an Editor for Nephrology Dialysis Transplantation and the American Journal of Nephrology. He also served as an Associate Editor of NephSAP and the Journal of the American Society of Hypertension. He has had numerous invited lectures nationally and internationally.
Dr. Agarwal is an internationally recognized leader in the area of clinical and translational research in nephrology. He had chaired numerous event adjudication committees of trials related to diabetic nephropathy and developed methods to adjudicate end stage renal disease in this difficult group of patients. With funding from the National Institutes of Health he has recently uncovered through a randomized clinical trial the ill effects of parenteral iron in CKD. His foremost contribution has been in the area of hypertension in hemodialysis patients for which he has been funded since 2003 by the National Institutes of Health. He has refined the techniques to diagnose and treat hypertension in this complex group of patients and performed important randomized trials in this difficult group of patients. He has been federally funded since 2009 by the Veterans Administration and for uncovering the prevalence and mechanisms of masked hypertension in chronic kidney disease.